Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma

Fig. 7

CDH5, MMP9, MAPK1 and MMP13 expression and immunohistochemistry. Differences in the expression levels of CDH5, MMP9, MAPK1 and MMP13 in TCGA and GTEx combined data (A), CPTAC (B), GSE15641 (C), GSE36895 (D) and GSE53757 (E). (F) Immunohistochemical staining of CDH5, MMP9, MAPK1 and MMP13 in renal normal tissues and renal clear cell carcinoma. Note * p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us